Trials / Unknown
UnknownNCT05869357
Safety of Cream Containing Sericin and Turmeric in Healthy Volunteers
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The object of this study was to evaluate safety of cream containing sericin and turmeric in healthy volunteers.
Detailed description
There are 106 healthy volunteers in this study. Upper left arm is divided into 2 parts (2x2 cm) which are A and B area. Upper right arm is divided into 2 parts (2x2 cm) which are C and D area. Four area (A, B, C, and D) are randomized to receive cream containing 2.5% sericin and 2%turmeric, cream containing 5%sericin and 2%turmeric, cream containing 10%sericin and 2%turmeric, and cream base (Control group). Samples are applied 2 times/day for 6 days (Induction phase). Then, the volunteers will stop applying samples for 7 to 10 days (Free period). After that, Samples are applied 2 times/day for 3 days (Challenge phase). Erythema, melanin, humidity, transepidermal water loss, skin adverse reaction, and satisfaction are evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | cream containing 2.5% sericin and 2%turmeric | Sample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days. |
| OTHER | cream containing 5%sericin and 2%turmeric | Sample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days. |
| OTHER | cream containing 10%sericin and 2%turmeric | Sample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days. |
| OTHER | cream base | Sample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2023-10-30
- Completion
- 2023-11-30
- First posted
- 2023-05-22
- Last updated
- 2023-05-24
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05869357. Inclusion in this directory is not an endorsement.